ACTU CIK: 1652935

Actuate Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
3.00
FY24:
9.21
FY25:
13.6
(positive)
millions USD
FY23:
0
FY24:
0.11
FY25:
0.39
Total assets
Change from FY23 to FY25
millions USD
FY23:
3.00
FY24:
9.32
FY25:
14.0

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
6.92
FY24:
8.80
FY25:
5.71
(negative)
Change from FY23 to FY25
millions USD
FY23:
1.52
FY24:
0.41
FY25:
0.40
(positive)
Change from FY23 to FY25
millions USD
FY23:
−99.6
FY24:
0.10
FY25:
7.92
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
9.32
FY25:
14.0

All amounts in millions USD Data source:SEC EDGAR